165 related articles for article (PubMed ID: 31599440)
1. Omalizumab treatment in Samter's triad: case series and review of the literature.
Cameli P; Perruzza M; Salvini M; Fui A; Cekorja B; Refini RM; Sestini P; Bargagli E
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8124-8129. PubMed ID: 31599440
[TBL] [Abstract][Full Text] [Related]
2. A multicenter approach to evaluate omalizumab effectiveness in Samter's triad.
Cameli P; D'Alessandro M; Bergantini L; Silvestri E; Romaldi A; Emmi G; Parronchi P; Bargagli E
Monaldi Arch Chest Dis; 2020 Aug; 90(3):. PubMed ID: 32885934
[TBL] [Abstract][Full Text] [Related]
3. Aspirin sensitivity does not compromise quality-of-life outcomes in patients with Samter's triad.
Jang DW; Comer BT; Lachanas VA; Kountakis SE
Laryngoscope; 2014 Jan; 124(1):34-7. PubMed ID: 23712910
[TBL] [Abstract][Full Text] [Related]
4. Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up.
Yalcin AD; Uçar S; Gumuslu S; Strauss LG
Immunopharmacol Immunotoxicol; 2013 Aug; 35(4):524-7. PubMed ID: 23841472
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery.
Kim JE; Kountakis SE
Ear Nose Throat J; 2007 Jul; 86(7):396-9. PubMed ID: 17702319
[TBL] [Abstract][Full Text] [Related]
6. Samter's triad with aural involvement: a novel approach to management.
Sethukumar P; Heywood R; Narula A
J Laryngol Otol; 2014 Dec; 128(12):1114-6. PubMed ID: 25418960
[TBL] [Abstract][Full Text] [Related]
7. Samter's triad in childhood: a warning for those prescribing NSAIDs.
Ameratunga R; Randall N; Dalziel S; Anderson BJ
Paediatr Anaesth; 2013 Aug; 23(8):757-9. PubMed ID: 23782034
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life Study.
Tiotiu A; Oster JP; Roux PR; Nguyen Thi PL; Peiffer G; Bonniaud P; Dalphin JC; de Blay F
J Investig Allergol Clin Immunol; 2020; 30(1):49-57. PubMed ID: 30931917
[TBL] [Abstract][Full Text] [Related]
9. Aural polyps in Samter's triad: case report and literature review.
Shen J; Peterson M; Mafee M; Nguyen QT
Otol Neurotol; 2012 Jul; 33(5):774-8. PubMed ID: 22699987
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Aspirin on Moderate to Severe Asthmatic Patients with Aspirin Hypersensitivity, Chronic Rhinosinusitis, and Nasal Polyposis.
Arshi S; Darougar S; Nabavi M; Bemanian MH; Fallahpour M; Shokri S; Ahmadian J; Molatefi R; Rekabi M; Moinfar Z; Hashemitari P; Eslami N
Iran J Allergy Asthma Immunol; 2021 Jun; 20(3):287-293. PubMed ID: 34134450
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate: can it be a choice for nasal polyposis in aspirin exacerbated respiratory disease?
Buyukozturk S; Gelincik A; Aslan I; Aydin S; Colakoglu B; Dal M
J Asthma; 2009 Dec; 46(10):1037-41. PubMed ID: 19995143
[TBL] [Abstract][Full Text] [Related]
12. The Role of Surgery in Management of Samter's Triad: A Systematic Review.
Adelman J; McLean C; Shaigany K; Krouse JH
Otolaryngol Head Neck Surg; 2016 Aug; 155(2):220-37. PubMed ID: 27071444
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization.
Quint T; Dahm V; Ramazanova D; Arnoldner MA; Kurz H; Janik S; Brunner PM; Knerer-Schally B; Weninger W; Griss J; Ristl R; Schneider S; Bangert C
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):506-516.e6. PubMed ID: 34678497
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes following functional endoscopic sinus surgery in Samter's triad.
Olivier F; George M; Leuba D; Monnier P; Friedrich JP
J Laryngol Otol; 2015 Jun; 129(6):548-52. PubMed ID: 26074257
[TBL] [Abstract][Full Text] [Related]
15. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
Hayashi H; Fukutomi Y; Mitsui C; Kajiwara K; Watai K; Kamide Y; Nakamura Y; Hamada Y; Tomita Y; Sekiya K; Tsuburai T; Izuhara K; Wakahara K; Hashimoto N; Hasegawa Y; Taniguchi M
Am J Respir Crit Care Med; 2020 Jun; 201(12):1488-1498. PubMed ID: 32142372
[No Abstract] [Full Text] [Related]
16. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
[TBL] [Abstract][Full Text] [Related]
17. No difference in omalizumab efficacy in patients with asthma by number of asthma-related and allergic comorbidities.
Chen M; Choo E; Yoo B; Raut P; Haselkorn T; Pazwash H; Holweg CTJ; Hudes G
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):666-673. PubMed ID: 33465457
[TBL] [Abstract][Full Text] [Related]
18. Biologic Therapy in a Patient with Asthma and Nasal Polyps.
Caminati M; Senna G
J Allergy Clin Immunol Pract; 2019; 7(5):1700-1701. PubMed ID: 31076065
[No Abstract] [Full Text] [Related]
19. Samter's Triad to Aspirin-Exacerbated Respiratory Disease: Historical Perspective and Current Clinical Practice.
Krouse HJ; Krouse JH
ORL Head Neck Nurs; 2015; 33(4):14-8. PubMed ID: 26753248
[TBL] [Abstract][Full Text] [Related]
20. Dacryocystitis in a patient with Samter's triad.
Abdel-Aty A; Jin A; Manes RP; Khan M; Pointdujour-Lim R
Oman J Ophthalmol; 2022; 15(2):225-227. PubMed ID: 35937735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
